As a result, many racial and ethnic minorities, such as African Americans, Latinx individuals and Native Americans, must unjustly wait longer for a much-needed new organ – or never receive one at all because of these barriers to care.
Research shows that these disparities are avoidable, especially with changes at the institutional level.
The most recent data shows that, in 2016, the rate of kidney failure was highest among minority groups. For example, compared to whites, kidney failure was 9.5 times higher among Native Hawaiians and Pacific Islanders. Latinx individuals were over 50% more likely to be diagnosed with kidney failure than those who did not identify as Latinx.
Although minorities are more likely to be diagnosed with kidney failure, they are less likely to be transplanted. The majority of transplants in the U.S. go to whites.
These steps include a physician deciding that a transplant is medically suitable, the patient demonstrating interest in a transplant, a referral to a transplant center, completion of a pre-transplant evaluation and identification of a suitable living donor.
At each point of the transplant preparation process, there are opportunities for barriers to occur as a result of patient, provider, community and institutional factors. Together, these potentially create disparities in access.
Income level may play a role. Patients with organ failure who experience poverty, for instance, may face challenges covering the cost of their insurance co-payments, especially when they do not have comprehensive insurance or private insurance.
Literacy issues, such as gaps in formal education or English as a second language, may also impact a patient’s ability to understand the medical terminology involved in their treatment. This would affect their ability to communicate effectively with their providers.
Limited knowledge of the benefits of transplantation can also affect patients’ ability to access transplants. Patients who are unaware that transplantation is the preferred treatment may not complete the steps to transplant and instead remain on dialysis.
Given negative historical experiences, such as the Tuskegee Syphilis Study, some patients, especially those who have been historically disadvantaged or are currently marginalized, mistrust medical providers. As a result, they are less likely to seek medical assistance or trust that their providers are giving them accurate information.
Also, patients who report experiences of discrimination by their medical providers are less likely to seek transplantation. They may be discouraged from seeking further medical care because they expect poor treatment by providers.
I am a counseling psychologist whose research examines health inequities and treatment. Given the enormity of these factors, I conducted a study with my colleague, Heather Gardiner, director of the Health Disparities Research Lab at Temple University.
We sought to identify barriers to the pre-transplant evaluation for African American kidney patients. Patients who complete this evaluation successfully become active on the waitlist.
We looked at barriers at several levels: individual barriers, such as limited income; health barriers, such as having multiple health conditions in addition to kidney disease; educational barriers, such as limited knowledge about the kidney transplant process; and systemic barriers, such as long wait times for medical appointments. We also asked people what motivated them to pursue a transplant.
Our research leads us to believe that changing systemic problems will help address problems at the other levels.
For example, medical providers could consider condensing the medical appointments and testing period for the pre-transplant evaluation. Patients who are motivated to get off dialysis will be more motivated to complete the pre-transplant evaluation if they are able to complete the majority of their medical testing at one place over a short period, rather than having to attend several medical appointments over a long period of time.
Under the previous system, African Americans were more likely to die waiting for a liver transplant, because they generally had higher MELD scores, indicating that their disease was becoming worse. However, the current system prioritizes patients with high MELD scores, which has improved liver transplant rates for this group.
The 2014 policy change in kidney allocation allowed patients to count time spent on dialysis toward their total time spent on the waitlist, thereby reducing racial and ethnic disparities.
The success of these systemic changes illustrates the effectiveness of policy change. In my view, policies such as comprehensive Medicare coverage – with transportation assistance for all patients with kidney disease, for example – could potentially reduce many of the disparities along the steps to a successful transplant.